Literature DB >> 17133204

Impact of enhanced services on virologic outcomes in a directly administered antiretroviral therapy trial for HIV-infected drug users.

Duncan Smith-Rohrberg1, Joanne Mezger, Mary Walton, R Douglas Bruce, Frederick L Altice.   

Abstract

BACKGROUND: Directly administered antiretroviral therapy (DAART) is a promising intervention for improving HIV outcomes among active drug users, but the elements associated with successful DAART programs remain largely unknown. This study aimed to assess the impact of colocated medical, case management, and referral to substance abuse services (DAART-Plus) among the subjects receiving DAART as part of a larger randomized controlled trial comparing DAART with self-administered therapy.
METHODS: The health services utilization of 72 subjects receiving DAART was analyzed for its impact on changes in HIV-1 RNA levels at 6 months. The primary outcome was virologic success, defined as achieving an HIV-1 RNA level </=400 copies/mL or a >/=1.0 log10 reduction in HIV-1 RNA level. A second analysis consisted of linear regression assessing the effect of covariates on log10 HIV-1 RNA reduction from baseline to 6 months.
RESULTS: In multivariate analyses, achieving virologic success at 6 months was associated with high medical services utilization [adjusted odds ratio [AOR] = 10.0 (1.4, 73.9); P = 0.02] and with the use of case management services [AOR = 5.8 (1.1, 30.5); P = 0.04]. Both services resulted in a larger reduction in log10 HIV-1 RNA from baseline (difference in slopes: -0.9 and -1.0, respectively; P = 0.02 for both). Referral to off-site substance abuse services treatment did not significantly predict either virologic outcome.
CONCLUSIONS: Among individuals who receive DAART, the utilization of on-site medical and case management services was independently associated with improved virologic outcomes. These results suggest the potential utility of integrating these services into DAART interventions (DAART-Plus) targeting HIV-infected drug users with problematic adherence.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17133204     DOI: 10.1097/01.qai.0000248338.74943.85

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  31 in total

1.  Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapy.

Authors:  Duncan Smith-Rohrberg Maru; R Douglas Bruce; Mary Walton; Jo Anne Mezger; Sandra A Springer; David Shield; Frederick L Altice
Journal:  AIDS Behav       Date:  2007-12-18

2.  Directly administered antiretroviral therapy for HIV-infected drug users does not have an impact on antiretroviral resistance: results from a randomized controlled trial.

Authors:  Duncan Smith-Rohrberg Maru; Michael J Kozal; R Douglas Bruce; Sandra A Springer; Frederick L Altice
Journal:  J Acquir Immune Defic Syndr       Date:  2007-12-15       Impact factor: 3.731

3.  The role of at-risk alcohol/drug use and treatment in appointment attendance and virologic suppression among HIV(+) African Americans.

Authors:  Chanelle J Howe; Stephen R Cole; Sonia Napravnik; Jay S Kaufman; Adaora A Adimora; Beth Elston; Joseph J Eron; Michael J Mugavero
Journal:  AIDS Res Hum Retroviruses       Date:  2014-01-20       Impact factor: 2.205

4.  Depression and symptomatic response among HIV-infected drug users enrolled in a randomized controlled trial of directly administered antiretroviral therapy.

Authors:  Sandra A Springer; Shu Chen; Frederick Altice
Journal:  AIDS Care       Date:  2009-08

5.  Accessibility and utilization patterns of a mobile medical clinic among vulnerable populations.

Authors:  Britton A Gibson; Debarchana Ghosh; Jamie P Morano; Frederick L Altice
Journal:  Health Place       Date:  2014-05-21       Impact factor: 4.078

Review 6.  Linkage to care for HIV-infected heterosexual men in the United States.

Authors:  Nickolas D Zaller; Jeannia J Fu; Amy Nunn; Curt G Beckwith
Journal:  Clin Infect Dis       Date:  2011-01-15       Impact factor: 9.079

7.  Opioid Agonist Treatment and Improved Outcomes at Each Stage of the HIV Treatment Cascade in People Who Inject Drugs in Ukraine.

Authors:  Alyona Mazhnaya; Ruthanne Marcus; Martha J Bojko; Alexei Zelenev; Iuliia Makarenko; Iryna Pykalo; Sergii Filippovych; Sergii Dvoriak; Frederick L Altice
Journal:  J Acquir Immune Defic Syndr       Date:  2018-11-01       Impact factor: 3.731

8.  Rationale, study design and sample characteristics of a randomized controlled trial of directly administered antiretroviral therapy for HIV-infected prisoners transitioning to the community - a potential conduit to improved HIV treatment outcomes.

Authors:  Ali Shabahang Saber-Tehrani; Sandra A Springer; Jingjun Qiu; Maua Herme; Jeffrey Wickersham; Frederick L Altice
Journal:  Contemp Clin Trials       Date:  2011-11-12       Impact factor: 2.226

9.  Superiority of directly administered antiretroviral therapy over self-administered therapy among HIV-infected drug users: a prospective, randomized, controlled trial.

Authors:  Frederick L Altice; Duncan Smith-Rohrberg Maru; R Douglas Bruce; Sandra A Springer; Gerald H Friedland
Journal:  Clin Infect Dis       Date:  2007-08-13       Impact factor: 9.079

10.  Prevalence and Correlates of Unhealthy Alcohol and Drug Use Among Men Who Have Sex with Men Prescribed HIV Pre-exposure Prophylaxis in Real-World Clinical Settings.

Authors:  Onyema Ogbuagu; Brandon D L Marshall; Perry Tiberio; Adedotun Ogunbajo; Lydia Barakat; Madeline Montgomery; Alexi Almonte; Tyler Wray; Emily C Williams; E Jennifer Edelman; Philip A Chan
Journal:  AIDS Behav       Date:  2019-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.